Table 3 Vascular architecture of 144 renal lesions based on CDFI, SMI and MFI
CDFI | SMI | MFI | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
I | II | III | IV | V | I | II | III | IV | V | I | II | III | IV | V | |
Benign | 18 | 17 | 13 | 3 | 0 | 11 | 12 | 23 | 3 | 2 | 7 | 14 | 24 | 3 | 3 |
angiomyolipomas | 17 | 16 | 11 | 2 | 0 | 10 | 12 | 22 | 2 | 0 | 6 | 14 | 23 | 2 | 1 |
eosinophilic adenomas | 0 | 1 | 2 | 1 | 0 | 0 | 0 | 1 | 1 | 2 | 0 | 0 | 1 | 1 | 2 |
inflammatory pseudotumor | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
Malignance | 13 | 17 | 30 | 22 | 11 | 5 | 9 | 13 | 26 | 40 | 2 | 4 | 11 | 29 | 47 |
Clear cell carcinoma | 5 | 11 | 24 | 17 | 11 | 1 | 2 | 8 | 18 | 39 | 0 | 0 | 7 | 19 | 42 |
Papillary renal cell carcinoma | 3 | 2 | 4 | 1 | 0 | 1 | 3 | 3 | 5 | 1 | 0 | 2 | 2 | 5 | 4 |
chromophobe cell carcinoma | 4 | 4 | 2 | 3 | 0 | 2 | 4 | 2 | 2 | 0 | 1 | 2 | 2 | 5 | 0 |
Nephroblastic | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 |
mucinous carcinoma | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |